Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 10, Issue 5, Pages e004693
Publisher
BMJ
Online
2022-05-24
DOI
10.1136/jitc-2022-004693
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Generating natural killer cells for adoptive transfer: expanding horizons
- (2021) Soumyadipta Kundu et al. CYTOTHERAPY
- NK cell-based cancer immunotherapy: from basic biology to clinical development
- (2021) Sizhe Liu et al. Journal of Hematology & Oncology
- HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for “Off-the-Shelf” Immunotherapy
- (2021) Keven Hoerster et al. Frontiers in Immunology
- Combining AFM13, a bispecific CD30/CD16 antibody, with cytokine-activated cord blood-derived NK cells facilitates CAR-like responses against CD30+ malignancies
- (2021) Lucila N Kerbauy et al. CLINICAL CANCER RESEARCH
- Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy
- (2021) Kari A. Shaver et al. Frontiers in Immunology
- Human IL-15 Inhibits NK Cells Specific for Human NK-92 Cells
- (2021) HANS BERGMAN et al. ANTICANCER RESEARCH
- Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironment
- (2021) Uriel Y. Moreno-Nieves et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies
- (2021) Hasan Baysal et al. Frontiers in Immunology
- A Novel off-the-Shelf Trastuzumab-Armed NK Cell Therapy (ACE1702) Using Antibody-Cell-Conjugation Technology
- (2021) Hao-Kang Li et al. Cancers
- FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma
- (2021) Austin B. Bigley et al. Blood Advances
- Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy
- (2021) Melissa M Berrien-Elliott et al. BLOOD
- NK cells for cancer immunotherapy
- (2020) Noriko Shimasaki et al. NATURE REVIEWS DRUG DISCOVERY
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- The inner junction complex of the cilia is an interaction hub that involves tubulin post-translational modifications
- (2020) Ahmad Abdelzaher Zaki Khalifa et al. eLife
- Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
- (2020) Ombretta Melaiu et al. Frontiers in Immunology
- NK Cell Priming From Endogenous Homeostatic Signals Is Modulated by CIS
- (2020) Rebecca B. Delconte et al. Frontiers in Immunology
- Pembrolizumab plus allogeneic NK cells in advanced non–small cell lung cancer patients
- (2020) Mao Lin et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations
- (2020) Kellsye P Fabian et al. Journal for ImmunoTherapy of Cancer
- CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity
- (2020) Meisam Naeimi Kararoudi et al. BLOOD
- CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas
- (2020) Margery Gang et al. BLOOD
- Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity
- (2020) Huang Zhu et al. Cell Stem Cell
- Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers
- (2020) Soo-Chin Lee et al. CLINICAL CANCER RESEARCH
- Natural killer cells in cancer biology and therapy
- (2020) Song-Yang Wu et al. Molecular Cancer
- Human NK-92 Cells Function as Target Cells for Human NK Cells – Implications for CAR NK-92 Therapies
- (2020) HANS BERGMAN et al. ANTICANCER RESEARCH
- Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells
- (2020) May Daher et al. BLOOD
- Influence of KIR and NK Cell Reconstitution in the Outcomes of Hematopoietic Stem Cell Transplantation
- (2020) Fei Gao et al. Frontiers in Immunology
- Cord-Blood Natural Killer Cell-Based Immunotherapy for Cancer
- (2020) Xiaoyan Zhao et al. Frontiers in Immunology
- CAR-NK cells: A promising cellular immunotherapy for cancer
- (2020) Guozhu Xie et al. EBioMedicine
- FcRγ gene editing reprograms conventional NK cells to display key features of adaptive human NK cells.
- (2020) Weiru Liu et al. iScience
- CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide.
- (2020) Mark Gurney et al. HAEMATOLOGICA
- The role of natural killer cell in gastrointestinal cancer: killer or helper
- (2020) Feixue Wang et al. ONCOGENE
- B Cell Responses: Cell Interaction Dynamics and Decisions
- (2019) Jason G. Cyster et al. CELL
- Chimeric antigen receptor T cell persistence and memory cell formation
- (2019) Alexander D McLellan et al. IMMUNOLOGY AND CELL BIOLOGY
- Modulation of chimeric antigen receptor surface expression by a small molecule switch
- (2019) Alexandre Juillerat et al. BMC BIOTECHNOLOGY
- Pluripotent stem cell–derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity
- (2019) Huang Zhu et al. BLOOD
- The Effects of Household Medical Expenditures on Income Inequality in the United States
- (2018) Andrea S. Christopher et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Recipient T Cell Exhaustion and Successful Adoptive Transfer of Haploidentical Natural Killer Cells
- (2018) Robin L. Williams et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression
- (2018) Rika Fujii et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD38-NAD + Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response
- (2018) Shilpak Chatterjee et al. Cell Metabolism
- Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
- (2018) Ye Li et al. Cell Stem Cell
- Human T Cell Development, Localization, and Function throughout Life
- (2018) Brahma V. Kumar et al. IMMUNITY
- Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer
- (2018) Takeshi Ishikawa et al. INTERNATIONAL JOURNAL OF CANCER
- NK cell therapy for hematologic malignancies
- (2018) Rohtesh S. Mehta et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
- (2018) Kevin C. Barry et al. NATURE MEDICINE
- In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial
- (2018) O. Adotevi et al. OncoImmunology
- Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications
- (2017) Anushruti Sarvaria et al. Frontiers in Immunology
- The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
- (2017) Sourav Paul et al. Frontiers in Immunology
- CIS is a potent checkpoint in NK cell–mediated tumor immunity
- (2016) Rebecca B Delconte et al. NATURE IMMUNOLOGY
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele
- (2016) Caroline Jochems et al. Oncotarget
- Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma
- (2016) T. Kamiya et al. Cancer Immunology Research
- Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
- (2016) Hans Klingemann et al. Frontiers in Immunology
- Epigenetic Modification and Antibody-Dependent Expansion of Memory-like NK Cells in Human Cytomegalovirus-Infected Individuals
- (2015) Jaewon Lee et al. IMMUNITY
- Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients
- (2015) Susann Szmania et al. JOURNAL OF IMMUNOTHERAPY
- Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
- (2015) Richard W. Childs et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting the tumor microenvironment to improve natural killer cell-based immunotherapies: On being in the right place at the right time, with resilience
- (2015) Shannon Murray et al. Human Vaccines & Immunotherapeutics
- Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial
- (2015) Panagiotis D. Kottaridis et al. PLoS One
- Clinical utility of natural killer cells in cancer therapy and transplantation
- (2014) David A. Knorr et al. SEMINARS IN IMMUNOLOGY
- Platform for Induction and Maintenance of Transgene-free hiPSCs Resembling Ground State Pluripotent Stem Cells
- (2014) Bahram Valamehr et al. Stem Cell Reports
- Treatment of patients with advanced cancer with the natural killer cell line NK-92
- (2013) Torsten Tonn et al. CYTOTHERAPY
- Cutting Edge: Antibody-Dependent Memory-like NK Cells Distinguished by FcR Deficiency
- (2013) T. Zhang et al. JOURNAL OF IMMUNOLOGY
- Overexpression of CD38 Decreases Cellular NAD Levels and Alters the Expression of Proteins Involved in Energy Metabolism and Antioxidant Defense
- (2013) Yadong Hu et al. JOURNAL OF PROTEOME RESEARCH
- Cytokine activation induces human memory-like NK cells
- (2012) R. Romee et al. BLOOD
- Identification of human NK cells that are deficient for signaling adaptor FcR and specialized for antibody-dependent immune functions
- (2012) I. Hwang et al. INTERNATIONAL IMMUNOLOGY
- Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function
- (2011) B. Foley et al. BLOOD
- Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection
- (2011) S. Lopez-Verges et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of IL-15RA or an IL-15/IL-15RA fusion on CD8+ T cells modifies adoptively transferred T-cell function in cis
- (2009) Jesse Rowley et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cytokine-induced memory-like natural killer cells
- (2009) Megan A. Cooper et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
- (2008) S. Arai et al. CYTOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started